SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop

Chun‐Ping Cui(Queen Mary Hospital), Carmen Chak‐Lui Wong(Queen Mary Hospital), Alan Ka‐Lun Kai(Queen Mary Hospital), Daniel Wai‐Hung Ho(Queen Mary Hospital), Eunice Y. Lau(Hong Kong Polytechnic University), Yu‐Man Tsui(Queen Mary Hospital), Lo‐Kong Chan(Queen Mary Hospital), Tan To Cheung(Queen Mary Hospital), Ksh Chok(Queen Mary Hospital), Albert Chan(Queen Mary Hospital), Regina Cheuk‐Lam Lo(Queen Mary Hospital), Joyce Man‐Fong Lee(Queen Mary Hospital), Terence K. Lee(Hong Kong Polytechnic University), Irene Oi‐Lin Ng(Queen Mary Hospital)
Cited by 215Open Access
Full Text

Abstract

OBJECTIVE: We investigated the effect and mechanism of hypoxic microenvironment and hypoxia-inducible factors (HIFs) on hepatocellular carcinoma (HCC) cancer stemness. DESIGN: HCC cancer stemness was analysed by self-renewal ability, chemoresistance, expression of stemness-related genes and cancer stem cell (CSC) marker-positive cell population. Specific small ubiquitin-like modifier (SUMO) proteases 1 (SENP1) mRNA level was examined with quantitative PCR in human paired HCCs. Immunoprecipitation was used to examine the binding of proteins and chromatin immunoprecipitation assay to detect the binding of HIFs with hypoxia response element sequence. In vivo characterisation was performed in immunocompromised mice and stem cell frequency was analysed. RESULTS: We showed that hypoxia enhanced the stemness of HCC cells and hepatocarcinogenesis through enhancing HIF-1α deSUMOylation by SENP1 and increasing stabilisation and transcriptional activity of HIF-1α. Furthermore, we demonstrated that SENP1 is a direct target of HIF-1/2α and a previously unrecognised positive feedback loop exists between SENP1 and HIF-1α. CONCLUSIONS: Taken together, our findings suggest the significance of this positive feedback loop between HIF-1α and SENP1 in contributing to the increased cancer stemness in HCC and hepatocarcinogenesis under hypoxia. Drugs that specifically target SENP1 may offer a potential novel therapeutic approach for HCC.


Related Papers

No related papers found

Powered by citation graph analysis